SG Americas Securities Boosts Chemours Stake by 478%

Investment firm significantly increases position in specialty chemicals company

Apr. 4, 2026 at 8:57am

Got story updates? Submit your updates here. ›

A high-contrast, black-and-white close-up image of complex industrial machinery and equipment used in chemical processing, conveying the scale and power of the modern chemicals industry.An institutional investor's substantial increase in its Chemours holdings reflects confidence in the specialty chemicals company's ability to navigate industry challenges.Wilmington Today

SG Americas Securities LLC grew its stake in The Chemours Company (NYSE: CC) by 478.4% during the fourth quarter, according to a recent SEC filing. The firm now owns 236,236 shares of the specialty chemicals company's stock, worth approximately $2.8 million.

Why it matters

This substantial increase in ownership by a major institutional investor signals confidence in Chemours' long-term prospects, despite the company facing some recent headwinds. The chemicals sector has seen volatility, making large position changes by savvy investors noteworthy.

The details

According to the 13F filing, SG Americas Securities purchased an additional 195,393 shares of Chemours during the quarter, bringing its total position to over 236,000 shares. This represents about 0.16% of the company's outstanding stock. Other large investors have also been active in Chemours, with firms like Wealth Enhancement Advisory Services and Penn Capital Management making notable moves.

  • The 13F filing covers the fourth quarter of 2025.
  • SG Americas Securities made the large increase in its Chemours stake during that time period.

The players

SG Americas Securities LLC

A major institutional investment firm that significantly boosted its position in Chemours.

The Chemours Company

A global specialty chemicals company headquartered in Wilmington, Delaware.

Got photos? Submit your photos here. ›

The takeaway

The sizable investment by SG Americas Securities underscores the potential that savvy institutional investors see in Chemours, even as the chemicals sector navigates a period of volatility. This move could foreshadow broader market confidence in the company's ability to weather current challenges and capitalize on future growth opportunities.